Financials Stille AB

Equities

STIL

SE0000998650

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm 11:05:18 2024-05-21 am EDT 5-day change 1st Jan Change
198 SEK +1.54% Intraday chart for Stille AB -1.98% +31.13%

Valuation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 444.1 754.5 561.5 757 1,752 - -
Enterprise Value (EV) 1 444.1 754.5 527.8 757 1,712 1,752 1,752
P/E ratio - 46.9 x - - - - -
Yield - - - - - - -
Capitalization / Revenue 3.11 x - 2.28 x 2.57 x 3.11 x 2.75 x 2.47 x
EV / Revenue 3.11 x - 2.14 x 2.57 x 3.03 x 2.75 x 2.47 x
EV / EBITDA - - 12.5 x 12.1 x 13.9 x 10.6 x 9.31 x
EV / FCF - - 22,088,270 x 31,059,165 x - - -
FCF Yield - - 0% 0% - - -
Price to Book - - - - - - -
Nbr of stocks (in thousands) 4,828 5,013 5,013 5,013 8,985 - -
Reference price 2 92.00 150.5 112.0 151.0 195.0 195.0 195.0
Announcement Date 2/18/21 2/17/22 2/17/23 2/16/24 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 142.6 - 246.4 294.9 564.2 637.6 710.2
EBITDA 1 - - 42.1 62.6 123.3 165.8 188.2
EBIT 1 - - 32.41 48.3 95.4 133.9 152.7
Operating Margin - - 13.15% 16.38% 16.91% 21% 21.5%
Earnings before Tax (EBT) - - - - - - -
Net income 8.273 16.1 - - - - -
Net margin 5.8% - - - - - -
EPS - 3.210 - - - - -
Free Cash Flow - - 23.9 24.37 - - -
FCF margin - - 9.7% 8.27% - - -
FCF Conversion (EBITDA) - - 56.76% 38.94% - - -
FCF Conversion (Net income) - - - - - - -
Dividend per Share - - - - - - -
Announcement Date 2/18/21 2/17/22 2/17/23 2/16/24 - - -
1SEK in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 61.6 63.3 - 61.84 - 75.09 70.11 77.3 139.7 141.6 134.3 148.6
EBITDA 1 9.8 11.2 - - - 15.7 15.5 17.7 17 31.9 33.6 40.9
EBIT 1 7.5 8.9 - - - 11.95 11.92 14 10.3 24.8 26.9 33.4
Operating Margin 12.18% 14.06% - - - 15.91% 17.01% 18.11% 7.37% 17.51% 20.03% 22.48%
Earnings before Tax (EBT) - - - - - - - - - - - -
Net income - - 6.514 - 3.417 - - - - - - -
Net margin - - - - - - - - - - - -
EPS - - 1.300 - 0.6800 - - - - - - -
Dividend per Share - - - - - - - - - - - -
Announcement Date 4/28/22 7/15/22 10/27/22 2/17/23 4/27/23 7/14/23 10/26/23 2/16/24 4/25/24 - - -
1SEK in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - -
Net Cash position 1 - - 33.7 - 40 - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow - - 23.9 24.4 - - -
ROE (net income / shareholders' equity) - - 16.2% - - - -
ROA (Net income/ Total Assets) - - - - - - -
Assets - - - - - - -
Book Value Per Share - - - - - - -
Cash Flow per Share - - - - - - -
Capex 1 - - 2.13 1.41 5 6 -
Capex / Sales - - 0.86% 0.48% 0.89% 0.94% -
Announcement Date 2/18/21 2/17/22 2/17/23 2/16/24 - - -
1SEK in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly revenue - Rate of surprise

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW